Seres And Ferring Go Head-To-Head In Recurrent C. Difficile Market

Two New Microbiome Medicines Launched In 2023

 
• By David Wild
  
Patients with recurrent C. difficile now have two comparable treatments • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Market Access

More from In Vivo